Transport of free 211At and 125I− in thyroid epithelial cells: effects of anion channel blocker 4,4′-diisothiocyanostilbene-2,2′-disulfonic acid on apical efflux and cellular retention

IntroductionAstatine (211At; α-emitter; t1/2=7.21 h) shares several features with its halogen neighbour iodine. In the present study, we investigated whether 4,4′-diisothiocyanostilbene-2,2′-disulfonic acid (DIDS) can be used to increase the cellular retention time of 211At and radioiodide in thyroid epithelial cells.MethodsThe transepithelial transport and cellular uptake of 211At and 125I− were studied simultaneously in porcine thyrocytes cultured in bicameral chambers. The cells were prestimulated with thyroid-stimulating hormone (TSH) or epidermal growth factor (EGF) for 48 h. In addition, the acute effects of DIDS and forskolin were investigated.ResultsThe transepithelial transport of both radionuclides was stimulated by TSH and down-regulated by EGF. DIDS rapidly reduced the efflux and increased the cellular content of 125I− in control and TSH-stimulated cells, whereas DIDS had no effect on 125I− transport in EGF-treated cells. DIDS blocked the 211At efflux only in TSH-stimulated cells. Unexpectedly, DIDS caused an accelerated efflux of 211At in both control and EGF-stimulated cells and, furthermore, reduced the cellular content of 211At in the EGF-stimulated cultures. DIDS had no effect on the forskolin-induced efflux of the two radionuclides.ConclusionsThe magnitude of thyroidal 211At uptake and efflux is similar to that of 125I−, strongly dependent on the functional activity of the cells. However, 211At efflux likely involves several permeating mechanisms with different sensitivity to DIDS, which are at least partly not shared by 125I−. The results suggest that anion channel blockage is potentially useful to increase the absorbed dose from both 211At and radioiodine in NIS-expressing tumours.